Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Carcinoid Syndrome”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03453489
What this trial is testing

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Who this might be right for
Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Barbara Ann Karmanos Cancer Institute 4
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT05756608
What this trial is testing

Fibrosis in Chronic and Delayed Myocardial Infarction

Who this might be right for
Aortic StenosisChemotherapy Induced Systolic DysfunctionCarcinoid Syndrome
University of Edinburgh 180
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT03498040
What this trial is testing

Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

Who this might be right for
Carcinoid Heart Disease
Hospices Civils de Lyon 670
Not applicableStudy completedNCT01234168
What this trial is testing

Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Ipsen 340
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Large-scale testing (Phase 3)Study completedNCT02063659
What this trial is testing

Telotristat Etiprate for Carcinoid Syndrome Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT00853047
What this trial is testing

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 23
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01932528
What this trial is testing

An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 8
Large-scale testing (Phase 3)Study completedNCT02026063
What this trial is testing

Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 124
Large-scale testing (Phase 3)Study completedNCT01677910
What this trial is testing

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 135
Testing effectiveness (Phase 2)Ended earlyNCT00884715
What this trial is testing

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Endo USA Inc., a Keenova Therapeutics Company 10
Testing effectiveness (Phase 2)WithdrawnNCT01172717
What this trial is testing

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Boston Medical Center
Large-scale testing (Phase 3)WithdrawnNCT04065165
What this trial is testing

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome

Who this might be right for
Small Intestinal NETCarcinoid Heart Disease
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableWithdrawnNCT01371045
What this trial is testing

Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs

Who this might be right for
Acromegaly
Cedars-Sinai Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01018953
What this trial is testing

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 8
Load More Results